Helen Moyses

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Hepatology · 2014 · 306 citations

Pathology, Epa Enrichment, Fatty Liver Disease +18

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles et al. · Gastroenterology · 2020 · 208 citations · Full text

Dysbiosis, Microbiota, Gut Microbiology +7

Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Malcolm West, Rónan Astin, Helen Moyses et al. · Acta Oncologica · 2019 · 74 citations · Full text

Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial

Stephen Poole, Alex Tanner, Vasanth V Naidu et al. · Journal of Infection · 2022 · 59 citations

Molecular Point-of-care, Antibiotics, Safe Antibiotic De-escalation +8

Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease

Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles et al. · Contemporary Clinical Trials · 2018 · 36 citations · Full text

Metabolic Syndrome, Probiotic, Dysbiosis +12